ResearcherNagasaki UniversityActive in the last 2 years
Tomonori Araki
Matched on ORCID iD 0000-0002-6811-1415; OpenAlex author ID A5055291594. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2025: 2 papers · 2026: 2 papers
Papers 4
- Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil, and folini… Co-author DOI 10.1002/ijc.70072↗
- Dynamic analysis of C-reactive protein/albumin ratio in pancreatic cancer Co-author DOI 10.21203/rs.3.rs-8417823/v1↗
- Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 Studie… Co-author DOI 10.1159/000542137↗
- Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from … Co-author DOI 10.1177/17588359251320768↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Junichi Nakazawa · 4 shared papers, 2025–2026 · strength 0.73
- Paper Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposo… DOI 10.1002/ijc.70072↗
- Paper Dynamic analysis of C-reactive protein/albumin ratio in pancreatic cancer DOI 10.21203/rs.3.rs-8417823/v1↗
- Paper Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patien… DOI 10.1177/17588359251320768↗
- Kenji Mitsugi · 4 shared papers, 2025–2026 · strength 0.73
- Paper Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposo… DOI 10.1002/ijc.70072↗
- Paper Dynamic analysis of C-reactive protein/albumin ratio in pancreatic cancer DOI 10.21203/rs.3.rs-8417823/v1↗
- Paper Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patien… DOI 10.1177/17588359251320768↗
- Shiho Arima · 4 shared papers, 2025–2026 · strength 0.73
- Paper Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposo… DOI 10.1002/ijc.70072↗
- Paper Dynamic analysis of C-reactive protein/albumin ratio in pancreatic cancer DOI 10.21203/rs.3.rs-8417823/v1↗
- Paper Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patien… DOI 10.1177/17588359251320768↗
- Futa Koga · 4 shared papers, 2025–2026 · strength 0.73
- Paper Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposo… DOI 10.1002/ijc.70072↗
- Paper Dynamic analysis of C-reactive protein/albumin ratio in pancreatic cancer DOI 10.21203/rs.3.rs-8417823/v1↗
- Paper Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patien… DOI 10.1177/17588359251320768↗
- Mototsugu Shimokawa · 4 shared papers, 2025–2026 · strength 0.73
- Paper Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposo… DOI 10.1002/ijc.70072↗
- Paper Dynamic analysis of C-reactive protein/albumin ratio in pancreatic cancer DOI 10.21203/rs.3.rs-8417823/v1↗
- Paper Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patien… DOI 10.1177/17588359251320768↗
- Taiga Otsuka · 4 shared papers, 2025–2026 · strength 0.73
- Paper Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposo… DOI 10.1002/ijc.70072↗
- Paper Dynamic analysis of C-reactive protein/albumin ratio in pancreatic cancer DOI 10.21203/rs.3.rs-8417823/v1↗
- Paper Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patien… DOI 10.1177/17588359251320768↗
- Tsuyoshi Shirakawa · 4 shared papers, 2025–2026 · strength 0.73
- Paper Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposo… DOI 10.1002/ijc.70072↗
- Paper Dynamic analysis of C-reactive protein/albumin ratio in pancreatic cancer DOI 10.21203/rs.3.rs-8417823/v1↗
- Paper Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patien… DOI 10.1177/17588359251320768↗
- Kazuo Nishikawa · 4 shared papers, 2025–2026 · strength 0.73
- Paper Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposo… DOI 10.1002/ijc.70072↗
- Paper Dynamic analysis of C-reactive protein/albumin ratio in pancreatic cancer DOI 10.21203/rs.3.rs-8417823/v1↗
- Paper Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patien… DOI 10.1177/17588359251320768↗
- Hiroki Taguchi · 4 shared papers, 2025–2026 · strength 0.73
- Paper Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposo… DOI 10.1002/ijc.70072↗
- Paper Dynamic analysis of C-reactive protein/albumin ratio in pancreatic cancer DOI 10.21203/rs.3.rs-8417823/v1↗
- Paper Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patien… DOI 10.1177/17588359251320768↗
- Shuji Arita · 4 shared papers, 2025–2026 · strength 0.73
- Paper Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposo… DOI 10.1002/ijc.70072↗
- Paper Dynamic analysis of C-reactive protein/albumin ratio in pancreatic cancer DOI 10.21203/rs.3.rs-8417823/v1↗
- Paper Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patien… DOI 10.1177/17588359251320768↗
- Yasunori Kawaguchi · 4 shared papers, 2025–2026 · strength 0.73
- Paper Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposo… DOI 10.1002/ijc.70072↗
- Paper Dynamic analysis of C-reactive protein/albumin ratio in pancreatic cancer DOI 10.21203/rs.3.rs-8417823/v1↗
- Paper Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patien… DOI 10.1177/17588359251320768↗
- Yasushi Ide · 3 shared papers, 2025–2026 · strength 0.56
- Paper Chemotherapy-induced neutropenia predicts short-term outcome of patients with pancreatic cancer treated with nanoliposo… DOI 10.1002/ijc.70072↗
- Paper Dynamic analysis of C-reactive protein/albumin ratio in pancreatic cancer DOI 10.21203/rs.3.rs-8417823/v1↗
- Paper Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Ca… DOI 10.1159/000542137↗
- Taro Shibuki · 2 shared papers, 2025 · strength 0.33
- Paper Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patien… DOI 10.1177/17588359251320768↗
- Paper Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Ca… DOI 10.1159/000542137↗
- Keisuke Miwa · 2 shared papers, 2025 · strength 0.33
- Paper Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patien… DOI 10.1177/17588359251320768↗
- Paper Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Ca… DOI 10.1159/000542137↗
- Azusa Komori · 2 shared papers, 2025 · strength 0.33
- Paper Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patien… DOI 10.1177/17588359251320768↗
- Paper Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Ca… DOI 10.1159/000542137↗
- Norio Ureshino · 1 shared paper, 2025 · strength 0.16
- Masaru Fukahori · 1 shared paper, 2025 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.